Science News

TEL AVIV, Israel & ENGLEWOOD, N.J.--(BUSINESS WIRE)--101 Therapeutics releases evidence package for 101-PGC-005, seeking  independent review for therapeutic use in Bundibugyo Ebola crisis....

STOCKHOLM--(BUSINESS WIRE)--Giving mice a chemically induced epileptic condition and then adding nicotine does not prove that nicotine causes or worsens seizures, according to Haypp Group's recently published criticism of a laboratory study on nicotine pouches. The animal experiment used kainic acid, a well-known compound that is deliberately used to trigger seizures in mice. Before seizures were induced, researchers exposed them to nicotine pouches or cannabidiol (CBD), reporting changes in se...

ESPOO, Finland & MUNICH--(BUSINESS WIRE)--IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). Ciesla, an experienced deep...

YOKOHAMA, Japan--(BUSINESS WIRE)--Astrogen, a South Korean biotech company, wins the 18th Folia Award for its autism clinical research, accelerating its expansion into global markets....

NEW YORK--(BUSINESS WIRE)--Dante Labs enabled more than 100 global scientific studies on rare diseases, transcriptomics, CRISPR gene editing ancient DNA samples and oncology. Dante Labs also published its own papers on peer reviewed journals, including Gene and Nature Communications. Scientists and academic researchers from the US, Italy, Pakistan, Malta and more European countries keep choosing Dante Labs to sequence samples for important studies. Topics include rare diseases, phasing, oncolog...

BLOOMINGTON, Minn.--(BUSINESS WIRE)--Activate Learning announced today that the Activate Learning Digital Platform has been awarded the ISTE Seal, a rigorous validation program that evaluates and recognizes high-quality edtech solutions. The recognition follows an extensive evaluation by a distinguished panel of experts in education, instruction, and technology, confirming that the platform meets the highest standards in learning sciences, user experience, accessibility, and content quality. Th...

DENVER--(BUSINESS WIRE)--Craig Hospital, a nationally recognized neurorehabilitation and research hospital specialized in the care of individuals who have sustained spinal cord and brain injuries, announced today it is joining SCI Ventures as an Alliance Partner, reinforcing a shared commitment to bring new therapies to persons living with paralysis. Through the partnership, Craig Hospital will invest in SCI Ventures, join the fund’s board of directors, and contribute clinical expertise and dir...

INDIANAPOLIS--(BUSINESS WIRE)--Kovina Therapeutics Inc. today announced publication in the Proceedings of the National Academy of Sciences (PNAS) of research validating its HPV E6 targeted therapeutic approach. The publication, “Covalent Inhibitors of Human Papillomavirus Type 16 E6 Protein Restore p53 Function and Suppress Growth of HPV-Driven Tumors in vivo,” reports that small molecules developed through Kovina’s HPV E6 program restore p53 tumor suppressor activity, induce apoptosis and sene...

BEAUFORT, S.C.--(BUSINESS WIRE)--Since 1995, the number of U.S. citizens with PAD has approximately doubled from 11 million to over 22 million. PAD is extremely costly with a current economic burden of $352-$694 billion, accounting for 7%-13% of National Health Expenditures.“Although PAD prevalence exceeds that of heart disease and stroke, compared to these other cardiovascular diseases, PAD remains underappreciated. PAD is a significant source of morbidity and mortality, as well as a major caus...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Celebrating Excellence: Life Sciences BC Announces 2026 Award Winners...